[83]
Novopharm also argues that Dr. Liston, the witness for Abbott, acknowledged in his evidence that this information could be confidential. After describing the general attributes of a Form 3011, Dr. Liston states:
"26.
Apart from the non-medicinal ingredients
, this document is in no way confidential, nor does it contain any confidential information. The non-medicinal ingredients are discussed below.
. . . . .
"45.
There can certainly be cases in which the list of the inactive ingredients in a tablet or capsule could amount to confidential or proprietary information. It may be that the list of ingredients is a complicated or sophisticated selection of materials that cannot easily be reproduced and that has value to the person who develops the 'formulation'.
" (Emphasis added)